ENZON PHARMACEUTICALS, INC. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (10)
- Human Resources (22)
- Real Estate (2)
- Uncategorized (24)
- Second Amendment to the Section 382 Rights Agreement, dated as of May 16, 2024, by and between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 22, 2024)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on March 20, 2024)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 16, 2023)
- Form of Indemnification Agreement (Filed With SEC on April 26, 2022)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 25, 2022)
- Independent Contractor Agreement, effective as of February 24, 2022, between Enzon Pharmaceuticals, Inc. and Richard L. Feinstein (Filed With SEC on February 25, 2022)
- First Amendment to the Section 382 Rights Agreement, dated as of June 4, 2021 and effective as of June 2, 2021, by and between Enzon Pharmaceuticals, Inc. and Continental Stock... (Filed With SEC on June 8, 2021)
- Description of Enzon Pharmaceuticals, Inc.s Registered Securities (Filed With SEC on February 23, 2021)
- Form of Subscription Agent Agreement (Filed With SEC on September 15, 2020)
- Form of Subscription Rights Certificate (Filed With SEC on September 15, 2020)
- INVESTMENTAGREEMENT BYAND BETWEEN ENZONPHARMACEUTICALS, INC. AND ICAHNCAPITAL LP DATEDAS OF SEPTEMBER 1, 2020 (Filed With SEC on September 1, 2020)
- Investment Agreement, dated as of September 1, 2020, by and between the Registrant and Icahn Capital LP (Filed With SEC on September 1, 2020)
- Section 382Rights Agreement Datedas of August 14, 2020 byand between ENZON PHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY as Rights Agent (Filed With SEC on August 14, 2020)
- Description of Registrants Securities (Filed With SEC on February 19, 2020)
- Letter Agreement, dated January 30, 2019, between Servier IP UK Limited and Enzon Pharmaceuticals, Inc (Filed With SEC on February 21, 2019)
- Amended and Restated Exclusive IP Marketing Agreement, dated as of June 28, 2004, by and between Microment AG and Enzon Pharmaceuticals, Inc (Filed With SEC on February 21, 2019)
- SECOND AMENDMENT TO SECTION 382 RIGHTSAGREEMENT (Filed With SEC on March 24, 2017)
- AMENDMENT 2 TO SEPARATION AGREEMENT (Filed With SEC on May 9, 2016)
- AMENDMENT TO SEPARATION AGREEMENT (Filed With SEC on May 9, 2016)
- FIRST AMENDMENT TO SECTION 382 RIGHTSAGREEMENT (Filed With SEC on March 21, 2016)
- AGREEMENT (Filed With SEC on March 21, 2016)
- EnzonPharmaceuticals, Inc. 20Kingsbridge Road Piscataway,NJ 08854 (Filed With SEC on March 21, 2016)
- AMENDMENT1 INDEPENDENTCONTRACTOR AGREEMENT (Filed With SEC on March 21, 2016)
- PLAN OFLIQUIDATION AND DISSOLUTION OF enzon pharmaceuticals, inc. (Filed With SEC on February 9, 2016)
- ASSIGNMENT, ASSUMPTION AND RELEASE AGREEMENT (Filed With SEC on November 6, 2015)
- Section382 Rights Agreement Datedas of May 1, 2014 byand between ENZONPHARMACEUTICALS, INC. and CONTINENTALSTOCK TRANSFER & TRUST COMPANY asRights Agent (Filed With SEC on May 1, 2014)
- ______________________________________________________________________________ AMENDED AND RESTATED AGREEMENT OF SUBLEASE BETWEEN ENZON PHARMACEUTICALS, INC., AS SUBLANDLORD, AND... (Filed With SEC on March 14, 2014)
- INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 14, 2014)
- SEPARATIONAGREEMENT (Filed With SEC on March 14, 2014)
- AGREEMENT OF SUBLEASE BETWEEN ENZON PHARMACEUTICALS, INC., AS SUBLANDLORD, AND AXCELLERATE PHARMA, LLC, AS SUBTENANT PREMISES: PORTION OF 20 KINGSBRIDGE ROAD PISCATAWAY, NEW... (Filed With SEC on November 12, 2013)
- SEPARATIONAGREEMENT (Filed With SEC on November 12, 2013)
- ENZON PHARMACETICALS, INC Amended and Restated 2013 Outside DirectorCompensation Plan (Filed With SEC on August 6, 2013)
- ENZON PHARMACEUTICALS, INC. 2011 Outside Director Compensation Plan (Filed With SEC on March 18, 2013)
- ENZON PHARMACEUTICALS, INC. 2013 Outside Director Compensation Plan (Filed With SEC on March 18, 2013)
- SEVERANCEAGREEMENT AND RELEASE OF CLAIMS February 28, 2013 (Filed With SEC on February 28, 2013)
- GENERAL SEVERANCE AGREEMENT (Filed With SEC on February 12, 2013)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 9, 2012)
- SEVERANCE AGREEMENT AND RELEASE OF CLAIMS (Filed With SEC on August 3, 2012)
- AMENDED AND RESTATED GENERAL SEVERANCE AGREEMENT (Filed With SEC on November 23, 2011)
- AMENDMENT NO. 2 TO AMENDED AND RESTATED SEVERANCE AGREEMENT (Filed With SEC on June 18, 2010)
- Exhibit 2.1 EXECUTION VERSION ASSETPURCHASE AGREEMENT byand between KLEEPHARMACEUTICALS, INC., DEFIANTEFARMACUTICA, S.A. and SIGMA-TAUFINANZIARIA S.P.A., (solelyfor the purpose of... (Filed With SEC on November 12, 2009)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 3, 2009)
- AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on November 3, 2009)
- AMENDMENT NO. 2 OF EMPLOYMENT AGREEMENT (Filed With SEC on August 5, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- ENZON PHARMACEUTICALS, INC. 2001 INCENTIVE STOCK PLAN RESTRICTED STOCK AWARD Terms and Conditions (Filed With SEC on March 9, 2009)
- ENZON PHARMACEUTICALS, INC. 2001 INCENTIVE STOCK PLAN RESTRICTED STOCK UNIT AWARD Terms and Conditions (Filed With SEC on March 9, 2009)
- AMENDMENT TO OUTSTANDING AWARDS UNDER 2001 INCENTIVE STOCK PLAN March 5, 2009 (Filed With SEC on March 9, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED AS FOLLOWS **REDACTED**.... (Filed With SEC on March 9, 2009)
- ENZON PHARMACEUTICALS, INC. 2001 INCENTIVE STOCK PLAN NON-QUALIFIED STOCK OPTION Terms and Conditions (Filed With SEC on March 9, 2009)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on August 25, 2008)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 20, 2008)
- EX-10.28: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 29, 2008)
- SECOND AMENDMENT TO THE RIGHTS AGREEMENT (Filed With SEC on January 8, 2008)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED SEVERANCE AGREEMENT (Filed With SEC on November 13, 2007)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED SEVERANCE AGREEMENT (Filed With SEC on November 13, 2007)
- EX-10.1: EXECUTIVE DEFERRED COMPENSATION PLAN (Filed With SEC on November 1, 2007)
- EX-10.1: PURCHASE AGREEMENT (Filed With SEC on August 20, 2007)
- EX-10.1: 2007 OUTSIDE DIRECTOR COMPENSATION PLAN (Filed With SEC on August 2, 2007)
- EX-10.1: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2007)
- EX-10.2: 2007 OUTSIDE DIRECTOR COMPENSATION PLAN (Filed With SEC on May 4, 2007)
- Executive Deferred Compensation Plan (2006 Restatement) (Filed With SEC on August 3, 2006)
